LIFEVANTAGE CORP Inventory Write-down
LIFEVANTAGE CORP (LFVN) reported Inventory Write-down of $2.72 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-27
- LIFEVANTAGE CORP inventory write-down for the quarter ending 2026-06-30 was $83.00K.
- LIFEVANTAGE CORP inventory write-down for the quarter ending 2026-03-31 was $270.00K.
- LIFEVANTAGE CORP inventory write-down for the quarter ending 2025-06-30 was $0.00.
- LIFEVANTAGE CORP inventory write-down for the quarter ending 2025-03-31 was $0.00.
- LIFEVANTAGE CORP inventory write-down for fiscal 2026 was $2.72M.
- LIFEVANTAGE CORP inventory write-down for fiscal 2025 was $0.00.
- LIFEVANTAGE CORP inventory write-down for fiscal 2015 was $0.00.
- LIFEVANTAGE CORP inventory write-down for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
| Period end | Inventory Write-down 1 month | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $353.00K derived: sum of 2 quarters · filed 2026-08-27 | $2.72M 10-K · filed 2026-08-27 | ||
| 2026-03-31 | $270.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $2.64M 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | $2.37M 10-Q · filed 2026-02-04 | ||||
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $0.00 derived: sum of 2 quarters · filed 2026-08-27 | $0.00 10-K · filed 2026-08-27 | ||
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $0.00 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | $0.00 10-Q · filed 2026-02-04 | ||||
| 2015-06-30 | $0.00 10-K · filed 2015-09-01 | ||||
| 2014-06-30 | $0.00 10-K · filed 2015-09-01 | ||||
| 2013-06-30 | $3.92M 10-K · filed 2015-09-01 | ||||
| 2012-12-31 | $3.70M 10-Q · filed 2013-05-09 | ||||
| 2012-06-30 | $0.00 10-K · filed 2014-09-10 | ||||
| 2011-06-30 | $0.00 10-K · filed 2013-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |